As of 2025-07-18, the Intrinsic Value of Thorne Healthtech Inc (THRN) is 7.78 USD. This THRN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 10.19 USD, the upside of Thorne Healthtech Inc is -23.60%.
The range of the Intrinsic Value is 5.10 - 16.13 USD
Based on its market price of 10.19 USD and our intrinsic valuation, Thorne Healthtech Inc (THRN) is overvalued by 23.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 5.10 - 16.13 | 7.78 | -23.6% |
| DCF (Growth 10y) | 7.93 - 23.80 | 11.81 | 15.9% |
| DCF (EBITDA 5y) | 4.90 - 10.41 | 7.51 | -26.3% |
| DCF (EBITDA 10y) | 7.03 - 14.35 | 10.33 | 1.4% |
| Fair Value | 9.40 - 9.40 | 9.40 | -7.71% |
| P/E | 3.41 - 9.79 | 6.69 | -34.4% |
| EV/EBITDA | 2.53 - 5.49 | 3.91 | -61.6% |
| EPV | 0.35 - 0.54 | 0.44 | -95.7% |
| DDM - Stable | 3.91 - 15.31 | 9.61 | -5.7% |
| DDM - Multi | 6.18 - 18.98 | 9.34 | -8.3% |
| Market Cap (mil) | 550.67 |
| Beta | -0.01 |
| Outstanding shares (mil) | 54.04 |
| Enterprise Value (mil) | 561.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.47% |
| Cost of Debt | 4.25% |
| WACC | 8.33% |